At AC Immune, we are passionate about making a difference in the lives of people affected by Alzheimer’s and other neurodegenerative diseases. Our goal is to become the global leader in precision medicine of neurodegenerative diseases that are one of the biggest challenges facing society today and future generations.
Latest news
September 20, 2019
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ Program
September 17, 2019
Company information
Discover more about us, who we are, and how we innovate to improve neurodegenerative disease understanding and develop breakthrough therapies.
Product pipeline
One of the world’s largest Alzheimer’s product pipelines with complementary diagnostic agents driven by proprietary technology platforms.
